These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

761 related items for PubMed ID: 27225481

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. YY1 Is Required for Posttranscriptional Stability of SOX2 and OCT4 Proteins.
    Wallingford MC, Hiller J, Zhang K, Mager J.
    Cell Reprogram; 2017 Aug; 19(4):263-269. PubMed ID: 28682643
    [Abstract] [Full Text] [Related]

  • 4. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY, Sun XC.
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr 08; 47(4):284-290. PubMed ID: 29690669
    [Abstract] [Full Text] [Related]

  • 5. The Yin and Yang of YY1 in tumor growth and suppression.
    Khachigian LM.
    Int J Cancer; 2018 Aug 01; 143(3):460-465. PubMed ID: 29322514
    [Abstract] [Full Text] [Related]

  • 6. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L, Losi L, Leyvraz S, Benhattar J.
    PLoS One; 2015 Aug 01; 10(7):e0132977. PubMed ID: 26185996
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM, Kim M, Kim HJ, Jang MH, Park SY.
    Oncotarget; 2017 May 30; 8(22):36305-36318. PubMed ID: 28422735
    [Abstract] [Full Text] [Related]

  • 16. Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT).
    Bigdelou Z, Johari B, Kadivar M, Rismani E, Asadi Z, Rahmati M, Saltanatpour Z.
    J Cell Physiol; 2019 Dec 30; 234(12):22765-22774. PubMed ID: 31115051
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pluripotency transcription factors and cancer stem cells: small genes make a big difference.
    Liu A, Yu X, Liu S.
    Chin J Cancer; 2013 Sep 30; 32(9):483-7. PubMed ID: 23419197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.